Supply Chain

Managing supplies is a crucial part of moving medical products from the manufacturer to patient’s bedside. Efficient supply chains can reduce healthcare costs and make medical devices more affordable for patients and health systems. This news page includes content on supply shortages, inventory management, and procurement practices.

Missouri becomes latest plaintiff in lawsuits against PBMs, drug companies over skyrocketing insulin prices
The Missouri complaint mirrors those brought by the Federal Trade Commission, the state of Texas and Philadelphia-based Jefferson Health, among others, in that it’s focused on alleged collusion between pharmacy benefit managers and drug companies to control the price of insulin.
FDA announces Class I recall on anesthesia vaporizers due to risk of chemical exposure
Vapor 2000 and Vapor 3000 devices manufactured by Draegar were improperly cleaned after parts were soldered on, meaning toxic metals could mix with medical gases. Due to the high risk posed to patient health, this recall has earned the FDA’s most serious designation.
FDA issues warning over use of Boston Scientific stents after 167 injuries, 3 deaths
Boston Scientific sent all known customers a letter on December 19, 2025 alerting them to an issue with certain AXIOS Stent and Electrocautery Enhanced Delivery Systems. During deployment, the stents may not expand. This can cause severe, potentially life-threatening injury to patients. All recalled stents must be removed from clinical settings immediately.
ASNC reports shortage of cardiac amyloidosis radiotracers
The two vendors involved say supplies of PYP and HDP could be disrupted for months.
FDA recalls organ recovery kits due to low-grade plastic bags
The recall has been designated a Class I, the most serious type. Certain "convenience kits" manufactured by AVID Medical contain non–medical-grade bags that could expose organs to toxins, increasing the odds of a transplant recipient's body rejecting them.

Missouri state house capitol Jefferson City

Missouri becomes latest plaintiff in lawsuits against PBMs, drug companies over skyrocketing insulin prices

The Missouri complaint mirrors those brought by the Federal Trade Commission, the state of Texas and Philadelphia-based Jefferson Health, among others, in that it’s focused on alleged collusion between pharmacy benefit managers and drug companies to control the price of insulin.

FDA announces Class I recall on anesthesia vaporizers due to risk of chemical exposure

Vapor 2000 and Vapor 3000 devices manufactured by Draegar were improperly cleaned after parts were soldered on, meaning toxic metals could mix with medical gases. Due to the high risk posed to patient health, this recall has earned the FDA’s most serious designation.

warning safety alert recall healthcare issue

FDA issues warning over use of Boston Scientific stents after 167 injuries, 3 deaths

Boston Scientific sent all known customers a letter on December 19, 2025 alerting them to an issue with certain AXIOS Stent and Electrocautery Enhanced Delivery Systems. During deployment, the stents may not expand. This can cause severe, potentially life-threatening injury to patients. All recalled stents must be removed from clinical settings immediately.

ASNC reports shortage of cardiac amyloidosis radiotracers

The two vendors involved say supplies of PYP and HDP could be disrupted for months.

FDA recalls organ recovery kits due to low-grade plastic bags

The recall has been designated a Class I, the most serious type. Certain "convenience kits" manufactured by AVID Medical contain non–medical-grade bags that could expose organs to toxins, increasing the odds of a transplant recipient's body rejecting them.

Lawsuit alleges AFP imported unsafe HIV drugs from Turkey through gray market supply chains

Numerous “alternative funding programs” are named as defendants in what is a larger challenge of the right of these third-party organizations to import drugs from overseas, bypassing FDA regulations.

Large nonprofit health system sues PBMs, drug companies over insulin prices

Philadelphia-based Jefferson Health has accused the three biggest PBMs—Caremark, Express Scripts and Optum Rx—of a de facto collusion scheme involving the primary makers of insulin, Eli Lilly, Novo Nordisk and Sanofi. The lawsuit alleges rebates offered by the manufacturers unfairly burden self-insured and public health plans, like the one the health system uses for its employees.

FDA issues Class I recall on B. Braun microbore extensions due to risk of death

The extensions are used to supply patients with fluids and drugs through an IV line. Despite being labeled as having them, the devices do not contain an air-eliminating vent. Because there is a serious risk of air embolism associated with the error, the FDA has given this recall its most serious designation.